NCT05659121 is a NA clinical trial of robotic exoskeleton training in Stroke, sponsored by National University Hospital, Singapore.

Who is sponsoring NCT05659121?

NCT05659121 is sponsored by National University Hospital, Singapore.

What drugs are being tested in NCT05659121?

Interventions in NCT05659121: robotic exoskeleton training.

What condition does NCT05659121 study?

NCT05659121 studies Stroke, Spinal Cord Injuries, Spinal Cord Diseases.

Is NCT05659121 still recruiting?

NCT05659121 is currently completed. Last updated 3 March 2023.

Last reviewed 2023-03-03 · How we verify

NCT05659121

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Improving Mobility Via Robotic Exoskeletons in Local Rehabilitation Settings in Singapore

Completed NA Last updated 3 March 2023

What this trial tests

NA trial testing robotic exoskeleton training in Stroke in 375 participants. Completed in 31 December 2022.

Timeline

15 November 2018

Primary endpoint
31 December 2022

31 December 2022

Quick facts

Lead sponsor	National University Hospital, Singapore
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	non randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	375
Start date	15 November 2018
Primary completion	31 December 2022
Estimated completion	31 December 2022
Sites	2 locations across Singapore

Drugs / interventions tested

robotic exoskeleton training

Conditions studied

Stroke — all drugs for Stroke →
Spinal Cord Injuries — all drugs for Spinal Cord Injuries →
Spinal Cord Diseases — all drugs for Spinal Cord Diseases →

Sponsor

National University Hospital, Singapore

Who can join

Adults 21 to 90, any sex, with Stroke or Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The programme is designed to investigate the application of robotic exoskeleton in different levels of local rehabilitation facilities. Feasibilities, efficacy, cost-effectiveness, patient and therapist's view of the application of robotic exoskeleton will be evaluated.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Cost-effectiveness analysis of robotic exoskeleton versus conventional physiotherapy for stroke rehabilitation in Singapore from a health system perspective.
Shankar R, Tang N, Shafawati N, Phan P, et al · · 2025 · cited 4× · PMID 40623888 · DOI 10.1136/bmjopen-2024-095269
Overground robotic exoskeleton vs conventional therapy in inpatient stroke rehabilitation: results from a pragmatic, multicentre implementation programme.
Tam PK, Tang N, Kamsani NSB, Yap TY, et al · · 2025 · cited 4× · PMID 39762953 · DOI 10.1186/s12984-024-01536-1

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

NCT06615973 — Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke · recruiting
NCT07494890 — Measurement Properties of Mechanical Cost of Walking for Individuals With Walking Impairment · NA · recruiting
NCT07356011 — Exoskeleton for Balance · NA · recruiting
NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
NCT06704074 — Virtual Reality Task Oriented Training on Upper Limb Function in Stroke Patients · NA · recruiting

Other National University Hospital, Singapore trials

Trials by the same sponsor.

NCT06027983 — Chimeric Receptor T Cells With Trastuzumab in HER2+ Advanced Breast Cancer and Other Solid Tumors · Phase 1, PHASE2 · not yet recruiting
NCT07460505 — Mandibular Advancement to Reduce Ventricular Load and Improve Quality-of-life in Heart Failure · NA · not yet recruiting
NCT07319676 — Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas · Phase 1, PHASE2 · recruiting
NCT06983769 — CPAP vs MAD for OSA in Patients With Cognitive Impairment. A Randomized Clinical Trial · NA · recruiting
NCT07091175 — Dupilumab Therapy in Nephrotic Syndrome in Children · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05659121 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National University Hospital, Singapore
Last refreshed: 3 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05659121.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing